RecruitingNANCT06318962

Examining the Efficacy of a Digital Therapeutic to Prevent Suicidal Behaviors

Sponsor: University of Memphis

Trial Details

Condition	Suicidal Behaviors, Suicide Ideation, Depression/Anxiety
Intervention	Aviva
Phase	NA
Status	Recruiting
Participants	400
Est. Completion	1 Aug 2027
Last Updated	5 May 2026

Primary Outcome

Self Injurious Thoughts and Behaviors Interview Revised

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * at least 18 years old * suicidal ideation within the past week and/or a suicide attempt within the past 30 days * ability to complete the informed consent process * ownership of either an Apple iPhone iOS 11 or higher or an Android smartphone OS 8.1 or higher Exclusion Criteria: * an inability to complete informed consent procedures (e.g., acute intoxication, altered consciousness) * experiencing active psychosis or mania requiring hospitalization; (3) and inability to use a smartphone.

Trial Sites

Countries

United States

View Registry Entry

Related Analysis

Digital Therapeutic Trial for Suicide Prevention: Aviva App vs Standard Care in Primary Care Settings

New trial investigates Aviva, a smartphone-based digital therapeutic delivering Brief Cognitive Behavioral Therapy for suicide prevention in primary care settings. The 400-participant study targets individuals with recent suicidal ideation or attempts, addressing critical gaps in accessible, scalable mental health interventions.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service